Yozma

Imagine healthier plant-based meat alternatives that offer the texture, flavour, and appearance of animal proteins. Using innovations in enzymatic processing, we develop new protein texturizing technologies that create healthier plant-based products that mimic the texture of animal proteins. The texture of plant-based protein products still poses a barrier to convincing consumers to adopt alternatives to meat. But current approaches to creating plant-based meat substitutes are falling short in building a protein structure that mirrors a meaty texture experience. We help plant-based protein producers satisfy consumers’ desire for meaty texture and appearance. By improving texture, our techniques enhance the eating experience as well as the nutritional profile of plant-based products. The result: a more convincing, satisfying, and healthy alternative to replace animal-based foods.

Imagine healthier plant-based meat alternatives that offer the texture, flavour, and appearance of animal proteins. Using innovations in enzymatic processing, we develop new protein texturizing technologies that create healthier plant-based products that mimic the texture of animal proteins. The texture of plant-based protein products still poses a barrier to convincing consumers to adopt alternatives to meat. But current approaches to creating plant-based meat substitutes are falling short in building a protein structure that mirrors a meaty texture experience. We help plant-based protein producers satisfy consumers’ desire for meaty texture and appearance. By improving texture, our techniques enhance the eating experience as well as the nutritional profile of plant-based products. The result: a more convincing, satisfying, and healthy alternative to replace animal-based foods.

Fine Data Lab is a digital data analysis company offering digital marketing consulting, analytics, and data analytics solutions.

Illumigyn is focused on enhancing cervical cancer diagnostics through its innovative Gynescope, a compact imaging colposcope that integrates advanced machine vision technologies. This device offers high-resolution imaging with 15-micron detail and features multispectral illumination options, significantly improving the accuracy of cervical exams and minimizing the risk of misdiagnoses. By providing sophisticated imaging capabilities alongside support for complex interventional procedures, the Gynescope aims to deliver optimal clinical outcomes for patients. Through its technology, Illumigyn seeks to address the inherent subjectivity of traditional cervical examinations, ultimately contributing to earlier detection and improved management of cervical cancer.

OP.GG is an e-gaming data analytics company that specializes in creating detailed profiles for gamers by analyzing their gameplay data. This platform enables users to enhance their gaming skills by providing insights into their own performance as well as that of their opponents and friends. OP.GG currently offers services for popular games such as League of Legends, Overwatch, and PUBG, attracting over 28 million monthly users globally. Through its analytics, OP.GG aims to foster a better gaming ecosystem by equipping players with the necessary tools and information to improve their overall gaming experience.

The digital transformation of healthcare is accelerating, with the COVID-19 outbreak demonstrating the rapidly growing need to enable healthcare professionals to quickly and efficiently diagnose patients, using tele-medicine, well before they arrive at the hospital. Handheld Ultrasound devices are a safe and cost-effective way of achieving quick assessment of the patient. However, the training required to use them is extremely long. It takes at least a year to become an expert. Hence, only experts are capable of performing a scan. The OnSight AI solution brings a new approach that is based on Geometrical Deep Learning, making ultrasound accessible to medical teams without prior training, thus enabling remote diagnostics anywhere and by anyone. OnSight GO is a software-only solution that can be installed on any portable handheld ultrasound device (device agnostic) enabling the healthcare professional to acquire a high-quality scan within minutes. It tackles two challenges. First, it navigates the clinician (e.g., think about WAZE for the human anatomy) to acquire the anatomical window for imaging and captures the images needed for diagnostic assessment. Secondly, it evaluates the status and function of the targeted area or organ automatically. The OnSight core technology is generic and can be deployed on different organs and imaging modalities. The first application to be introduced to market is cardiac scan and cardio-functional assessment. OnSight was founded by the Weizmann Institute of Science (Israel) and New York University (USA) based on state-of-the-art machine learning and artificial intelligence expertise.

Todos Medical Ltd is an in vitro diagnostics company based in Rehovot, HaMerkaz, founded in 2009. The company specializes in testing solutions for breast cancer, Alzheimer's disease, and COVID-19. Its team comprises experts from various fields, including medicine, physics, biochemistry, digital signal processing, and electrical engineering, which contributes to its competitive edge in the market. Todos Medical generates all its revenue from the United States, focusing on innovative diagnostic approaches to improve patient outcomes.

Nanox Vision is a healthcare technology company that specializes in advanced medical imaging solutions. Incorporated in 2011 and based in Gibraltar, the company has developed the Nanox System, which provides Medical Screening as a Service (MSaaS) aimed at preventative healthcare. This system is built on proprietary cold cathode technology, originally derived from innovations in high-definition flat panel displays. After over two decades of research and development and substantial financial investment, Nanox has created a unique imaging platform that enhances X-ray capabilities. Central to this technology is a nano-scale chip developed using specialized nanofabrication techniques, which allows for increased power density and uniformity in imaging. The Nanox System is designed to support diverse applications in medical imaging and is complemented by additional peripheral technologies to maximize its real-world utility.

The digital transformation of healthcare is accelerating, with the COVID-19 outbreak demonstrating the rapidly growing need to enable healthcare professionals to quickly and efficiently diagnose patients, using tele-medicine, well before they arrive at the hospital. Handheld Ultrasound devices are a safe and cost-effective way of achieving quick assessment of the patient. However, the training required to use them is extremely long. It takes at least a year to become an expert. Hence, only experts are capable of performing a scan. The OnSight AI solution brings a new approach that is based on Geometrical Deep Learning, making ultrasound accessible to medical teams without prior training, thus enabling remote diagnostics anywhere and by anyone. OnSight GO is a software-only solution that can be installed on any portable handheld ultrasound device (device agnostic) enabling the healthcare professional to acquire a high-quality scan within minutes. It tackles two challenges. First, it navigates the clinician (e.g., think about WAZE for the human anatomy) to acquire the anatomical window for imaging and captures the images needed for diagnostic assessment. Secondly, it evaluates the status and function of the targeted area or organ automatically. The OnSight core technology is generic and can be deployed on different organs and imaging modalities. The first application to be introduced to market is cardiac scan and cardio-functional assessment. OnSight was founded by the Weizmann Institute of Science (Israel) and New York University (USA) based on state-of-the-art machine learning and artificial intelligence expertise.

Operator of a biotechnology company intended to discover molecule drug targets for immuno-oncology-targeted cancer and CNS therapy. The company specializes in research on new drugs that mainly study anti-cancer drugs and develops targeted and immunosuppressive drugs and new drugs for Alzheimer's dementia, enabling patients to get first-in-class cancer treatment therapies.

NextNine Ltd. is a developer of operational technology security management software, focusing on the protection of industrial and critical infrastructure from cyber security threats. The company's flagship platform facilitates centralized security management for SCADA and ICS environments, addressing vulnerabilities specific to proprietary processes and networks. NextNine's solutions are tailored for sectors such as oil, gas, mining, chemicals, energy, manufacturing, and defense, where the need for remote maintenance and support increases susceptibility to cyber attacks. In addition to its core security software, NextNine offers remote product service, technical support, training, and consulting. With over 6,000 global installations, the company has established itself as a leader in OT security, recognized for its contributions to enhancing cyber security in critical infrastructure. NextNine is headquartered in New York and has been a subsidiary of Honeywell International since 2017.

Kailight Photonics develops optical modules for the telecommunications industry. It offers tunable optical signal regenerator, an optical component that operates with regenerators, optical switches, add/drop multiplexers, and cross-connects. The company's optical transmission, signal regeneration, and wavelength conversion technology provides optical-networking solutions for systems vendors. It provides its products to long-haul network market segments. The company, formerly known as Chilight Technologies, was founded in 2000 and is headquartered in Rehovot, Israel with an additional office in Dallas, Texas. As of May 15, 2007, Kailight Photonics, Inc. operates as a subsidiary of Optium Corporation.

CogniTens, Ltd. specializes in three-dimensional optical measurement solutions aimed at enhancing efficiency in the automotive and manufacturing sectors. The company offers products such as Optigo, a portable dimensional measurement platform, and OptiCell, an automated 3D optical measurement system designed for recurring measurements on the production floor. Additionally, CogniTens develops software tools like CoreView Plan for planning measurement programs, and CoreView Pro for analyzing and reporting measurement data. Their solutions cater to various industrial engineering activities, including tooling, part production, assembly, and quality control, serving a diverse clientele that includes automotive manufacturers, tier 1 suppliers, and tool and die companies. Founded in 1995 and headquartered in Ramat Hasharon, Israel, CogniTens also maintains offices in North America, South America, Europe, and Asia.

Predix is a drug discovery and development company that uses a novel 3D Discovery and Optimization Engine for GPCR drug candidates and is taking its novel compounds into the clinic. The discovery engine uses a sophisticated proprietary algorithm, PREDICT(TM), for computer modeling the 3D structure of any GPCR target; advanced technologies HYPERION(TM) and RISS(TM) for rapid high-throughput in silico screening of millions of compounds against the 3D in silico model of the target; and an integrated medicinal/computational platform for lead optimization based on the receptor's structure (ICELR-3D(TM)) and predictive algorithms for important drug properties. In August, Predix and Physiome Sciences Inc. combined companies and expanded the expertise into ion channel drug discovery.

NextNine Ltd. is a developer of operational technology security management software, focusing on the protection of industrial and critical infrastructure from cyber security threats. The company's flagship platform facilitates centralized security management for SCADA and ICS environments, addressing vulnerabilities specific to proprietary processes and networks. NextNine's solutions are tailored for sectors such as oil, gas, mining, chemicals, energy, manufacturing, and defense, where the need for remote maintenance and support increases susceptibility to cyber attacks. In addition to its core security software, NextNine offers remote product service, technical support, training, and consulting. With over 6,000 global installations, the company has established itself as a leader in OT security, recognized for its contributions to enhancing cyber security in critical infrastructure. NextNine is headquartered in New York and has been a subsidiary of Honeywell International since 2017.

CogniTens, Ltd. specializes in three-dimensional optical measurement solutions aimed at enhancing efficiency in the automotive and manufacturing sectors. The company offers products such as Optigo, a portable dimensional measurement platform, and OptiCell, an automated 3D optical measurement system designed for recurring measurements on the production floor. Additionally, CogniTens develops software tools like CoreView Plan for planning measurement programs, and CoreView Pro for analyzing and reporting measurement data. Their solutions cater to various industrial engineering activities, including tooling, part production, assembly, and quality control, serving a diverse clientele that includes automotive manufacturers, tier 1 suppliers, and tool and die companies. Founded in 1995 and headquartered in Ramat Hasharon, Israel, CogniTens also maintains offices in North America, South America, Europe, and Asia.

Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases.

Predix is a drug discovery and development company that uses a novel 3D Discovery and Optimization Engine for GPCR drug candidates and is taking its novel compounds into the clinic. The discovery engine uses a sophisticated proprietary algorithm, PREDICT(TM), for computer modeling the 3D structure of any GPCR target; advanced technologies HYPERION(TM) and RISS(TM) for rapid high-throughput in silico screening of millions of compounds against the 3D in silico model of the target; and an integrated medicinal/computational platform for lead optimization based on the receptor's structure (ICELR-3D(TM)) and predictive algorithms for important drug properties. In August, Predix and Physiome Sciences Inc. combined companies and expanded the expertise into ion channel drug discovery.

HyWire Ltd., established in 1999 and headquartered in Netanya, Israel, specializes in the development, manufacturing, and marketing of silicon-based search and classification VLSI components and subsystems. The company focuses on providing high-end solutions for switching and routing equipment, addressing the growing demand for speed and capacity in Internet connectivity. As bandwidth requirements continue to rise due to an increasing number of users and various network applications such as video streaming, voice over IP, e-commerce, and enterprise services, HyWire's products are designed to meet these critical needs in the telecommunications landscape.

NextNine Ltd. is a developer of operational technology security management software, focusing on the protection of industrial and critical infrastructure from cyber security threats. The company's flagship platform facilitates centralized security management for SCADA and ICS environments, addressing vulnerabilities specific to proprietary processes and networks. NextNine's solutions are tailored for sectors such as oil, gas, mining, chemicals, energy, manufacturing, and defense, where the need for remote maintenance and support increases susceptibility to cyber attacks. In addition to its core security software, NextNine offers remote product service, technical support, training, and consulting. With over 6,000 global installations, the company has established itself as a leader in OT security, recognized for its contributions to enhancing cyber security in critical infrastructure. NextNine is headquartered in New York and has been a subsidiary of Honeywell International since 2017.

Predix is a drug discovery and development company that uses a novel 3D Discovery and Optimization Engine for GPCR drug candidates and is taking its novel compounds into the clinic. The discovery engine uses a sophisticated proprietary algorithm, PREDICT(TM), for computer modeling the 3D structure of any GPCR target; advanced technologies HYPERION(TM) and RISS(TM) for rapid high-throughput in silico screening of millions of compounds against the 3D in silico model of the target; and an integrated medicinal/computational platform for lead optimization based on the receptor's structure (ICELR-3D(TM)) and predictive algorithms for important drug properties. In August, Predix and Physiome Sciences Inc. combined companies and expanded the expertise into ion channel drug discovery.

Globecom Interactive Commerce, Inc. is a US-Israel company that specializes in broadband-enabled solutions for the presentation of products and services. Established in 1998 and headquartered in Chantilly, Virginia, the company has research and development facilities in Herzliya, Israel. Globecom is recognized for its innovative software solutions that facilitate the creation, management, and delivery of rich dynamic media across various platforms, enabling businesses to enhance the productivity of both new and existing Internet market channels.

Compugen Ltd. is a clinical-stage therapeutic discovery and development company headquartered in Holon, Israel. The company focuses on immuno-oncology, leveraging its unique computational discovery capabilities to identify novel drug targets and biological pathways for cancer therapeutics. Compugen's immuno-oncology pipeline includes several clinical-stage programs, such as COM701, an anti-PVRIG antibody, and COM902, an antibody targeting TIGIT, both designed for the treatment of solid tumors. Additionally, the company has early-stage programs addressing myeloid targets and various mechanisms of immune resistance. Compugen collaborates with notable partners, including Bayer Pharma AG and Bristol-Myers Squibb, to further research and develop its therapeutics. Founded in 1993, Compugen employs a hypothesis-driven approach to drug discovery, utilizing in silico methods for product candidate prediction and validation, enhancing its ability to meet unmet therapeutic needs in the pharmaceutical and biotech sectors.

Cardonet is a provider of IT support and technology services that focuses on maximizing revenue and supporting business growth. Established in 1999, the company offers a comprehensive range of managed IT services, including assistance with technical issues, server emergencies, office relocations, and data center design. Cardonet aims to enhance the buyer's experience in e-marketplaces by enabling the creation and maintenance of transactive catalogs, which can increase marketplace transactions. With a dedicated team, including active involvement from its directors, Cardonet is committed to delivering effective technology solutions that help businesses gain a competitive advantage.

HarmonyCom is a privately held, venture-backed telecommunications software solutions provider founded in 1997. It has its U.S. headquarters in Ann Arbor, Michigan with operations in London and Tel Aviv. The lead investor in HarmonyCom is Iscal Holdings, Ltd., a private Israeli investment company that focuses on emerging high-tech companies. Additional funding has been received from Yozma Venture Capital. HarmonyCom's premier product is Harmony, a software solution that automates and orchestrates the delivery of broadband data services, allowing for measurable improvements in customer satisfaction, faster time-to-market for new products, reduced operational costs, and improved accuracy of information.

NextNine Ltd. is a developer of operational technology security management software, focusing on the protection of industrial and critical infrastructure from cyber security threats. The company's flagship platform facilitates centralized security management for SCADA and ICS environments, addressing vulnerabilities specific to proprietary processes and networks. NextNine's solutions are tailored for sectors such as oil, gas, mining, chemicals, energy, manufacturing, and defense, where the need for remote maintenance and support increases susceptibility to cyber attacks. In addition to its core security software, NextNine offers remote product service, technical support, training, and consulting. With over 6,000 global installations, the company has established itself as a leader in OT security, recognized for its contributions to enhancing cyber security in critical infrastructure. NextNine is headquartered in New York and has been a subsidiary of Honeywell International since 2017.